Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
roflumilast camp-specific 3',5'-cyclic phosphodiesterase 4a small molecule NA drugbank , DGIDB Chronic Obstructive Airway Disease[MeSHID:D029424]
Bronchitis
Chronic[MeSHID:D029481]
Bronchial Spasm[MeSHID:D001986]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Eczema[MeSHID:D004485]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Dermatitis
Atopic[MeSHID:D003876]
Asthma[MeSHID:D001249]		 2.05 approved inhibitor
roflumilast camp-specific 3',5'-cyclic phosphodiesterase 4b small molecule NA drugbank , DGIDB Chronic Obstructive Airway Disease[MeSHID:D029424]
Bronchitis
Chronic[MeSHID:D029481]
Bronchial Spasm[MeSHID:D001986]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Eczema[MeSHID:D004485]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Dermatitis
Atopic[MeSHID:D003876]
Asthma[MeSHID:D001249]		 1.93 approved inhibitor
roflumilast camp-specific 3',5'-cyclic phosphodiesterase 4c small molecule NA drugbank , DGIDB Chronic Obstructive Airway Disease[MeSHID:D029424]
Bronchitis
Chronic[MeSHID:D029481]
Bronchial Spasm[MeSHID:D001986]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Eczema[MeSHID:D004485]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Dermatitis
Atopic[MeSHID:D003876]
Asthma[MeSHID:D001249]		 1.99 approved inhibitor
roflumilast camp-specific 3',5'-cyclic phosphodiesterase 4d small molecule NA drugbank , DGIDB Chronic Obstructive Airway Disease[MeSHID:D029424]
Bronchitis
Chronic[MeSHID:D029481]
Bronchial Spasm[MeSHID:D001986]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Eczema[MeSHID:D004485]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Dermatitis
Atopic[MeSHID:D003876]
Asthma[MeSHID:D001249]		 1.59 approved inhibitor
click here to return to the previous page